Editorial methodology · Verified July 2026
How we choose featured partners
A paying partner needs a 7.0 to be featured. A provider that pays us nothing needs a 7.5. That half-point gap is the whole commercial concession, and it is written into the code that builds every featured surface on this site. The 0 to 10 score itself never moves for money, in either direction.
Live example: Winona is featured as Our Top Pick at 8.4/10 and it pays us. Alloy leads the women's wing at 8.9/10, pays us nothing, and still holds first place in the rankings table.
Two lists doing two different jobs
The rankings are methodology output. Each of the 16 platforms gets a weighted score across cost, formulary, clinical depth, patient experience and transparency, and the table is those scores in descending order. Affiliate status is not an input to that calculation and no promotional decision writes back into it.
The featured surfacesare the homepage cards, the affiliate strip and the sticky bar. They exist to make money and we say so. A reader arriving with "just tell me where to start" intent gets a short answer there; a reader who wants to argue with us gets the full score-sorted table two scrolls down. Both are on the same page, and the featured pick carries its real score in both places.
Everything on the featured surfaces also appears in the rankings at the position its score earned. A commercial placement has never moved a row in the objective table.
The floor, and exactly who it lets in
Selection runs on the live roster, so this section changes when the data does. Against today's scores, the two-floor rule has three visible effects.
3 partners are eligible that a flat 7.5 would exclude
These score between 7.0 and 7.5 and pay us a commission, so they clear the partner floor. This is the concession, stated plainly.
- Wisp7.3/10B$99/mo
- Gala Health7.2/10C$79/mo
- MangoRx7.0/10C$99/mo
5 providers at the same scores stay out
Same score band, no commercial relationship, so they are not eligible for a featured slot. They keep their full row, their real price and their real position in the rankings table.
- Hers Menopause7.4/10D$79/mo
- Gennev7.1/10B$199 per visit
- Elektra Health7.0/10B$149 per visit
- Inner Balance7.0/10D$99/mo
- PeterMD7.0/10C$99/mo
1 paying partner still cannot be featured
Telos RX pays us and scores under 7.0, which puts the featured surfaces out of reach. Money buys eligibility, and only at a score we are willing to defend.
- Telos RX6.9/10D$129/mo
The four guardrails that keep this honest
A commercial concession without constraints is just pay-for-placement with better manners. These four are the constraints, and each one is checkable from the rendered page.
1. The label says Top Pick, never number one
A featured partner is called "Our Top Pick" or "Featured Partner". The words "#1", "best" and "highest-scored" are reserved for whoever actually leads on score, and the featured surfaces render them only when the featured provider is the leader.
2. The real score is always on screen
The featured pick shows its own score, unrounded and unhidden, on every surface it appears. A promotional slot never hides the number that would let you argue with it.
3. The actual score leader is named alongside
Wherever a featured partner appears above a higher-scored provider, the higher-scored provider is named in the same block, with its score and a link to its review. A reader who wants the merit answer gets it without leaving the card.
4. The rankings table stays score-sorted
Every objective surface, the homepage table, the wing rankings, the comparison pages, sorts strictly by score descending. Commission has never moved a row and a recompute check runs against the evidence file to catch it if anyone tries.
The worked example, live
The featured-pick override is currently switched on and it pins Winona to the Top Pick slot. Winona scores 8.4/10, holds a Transparency Grade B, is priced at $54/mo, and pays us a commission on a qualifying signup.
The highest-scored provider on the women's wing is Alloy at 8.9/10 with a Transparency Grade A and a verified $40/mo. It pays us nothing. It is first in the rankings table, it holds the cheapest all-in price we have verified, and it is named beside Winonaon the promotional cards. On the men's wing the score leader is Defy Medical at 7.6/10.
What the arrangement costs us is worth stating: the top slot on the women's wing rankings points at a provider we earn nothing from, and readers who follow the merit answer generate no revenue at all. That is the trade, and it holds because the rankings are the only asset this site has.
Every partner, every score and every price is listed on the featured partners page.
What would remove a partner
- A score that drops below 7.0 on re-verification. Eligibility is recomputed from the score at build time, so a drop takes the featured slot away without anyone having to remember.
- A corroborated billing-surprise pattern or an unanswered regulatory complaint, both of which also cap the Transparency Grade regardless of what the provider discloses.
- A published claim we can no longer verify. When a price stops being checkable, the fact drops to a reported label and the score moves with it.
The scoring rubric and the correction policy live in the editorial policy. The commercial relationships are in the affiliate disclosure. The score-sorted rankings are on the women's wing homepage and at the men's TRT rankings.
This is general information, not medical advice. A featured placement is a commercial decision about where a platform appears on this site and carries no clinical meaning. Choosing hormone therapy is a decision for you and a licensed clinician.